FDA Declares Painkiller Dangerous…Pulls It.
The opioid controversy isn’t a shy one. The state of Ohio just sued five major pharmaceutical companies for what they are calling a massive and widespread painkiller addiction problem. Opioids are ruining lives, all the while; pharma is promoting them as if the potential for these issues don’t exist. They are also encouraging doctors to prescribe them beyond the needed reasons (ah, the key to financial success as a pharmaceutical company).
The FDA said on Thursday that one painkiller, Opana ER, which is an extended release of a drug called oxymorphone, is being “too abused” by people. Essentially, addicts crush it up and inject it. So the FDA wants it gone.
“Today, the U.S. Food and Drug Administration requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market,” the FDA said in a statement.
“After careful consideration, the agency is seeking removal based on its concern that the benefits of the drug may no longer outweigh its risks. This is the first time the agency has taken steps to remove a currently marketed opioid pain medication from sale due to the public health consequences of abuse.”
The company, Endo, isn’t taking this lying down. In fact, they say the drug is safe and effective.
“Endo is reviewing the request and is evaluating the full range of potential options as we determine the appropriate path forward,” Endo said in a statement.
“Despite the FDA’s request to withdraw Opana ER from the market, this request does not indicate uncertainty with the product’s safety or efficacy when taken as prescribed.”
In some ways, I don’t side with the FDA. It would seem to me that they are using one less prevalent drug to make it seem as though they have finally begun taking the issue seriously. Remember, they approved all these drugs. Remember, pharmaceutical companies donate heavily to campaigns, both national and local.
“We are facing an opioid epidemic – a public health crisis, and we must take all necessary steps to reduce the scope of opioid misuse and abuse,” FDA commissioner Dr. Scott Gottlieb said in a statement.
Author: Jim Satney
PrepForThat’s Editor and lead writer for political, survival, and weather categories.